Hantz Financial Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-151
| Closed | -$28K | – | 884 |
|
|
2021
Q2 | $28K | Sell |
151
-69
| -31% | -$12.8K | ﹤0.01% | 589 |
|
|
2021
Q1 | $34K | Sell |
220
-7,314
| -97% | -$1.13M | ﹤0.01% | 532 |
|
|
2020
Q4 | $1.18M | Sell |
7,534
-121
| -2% | -$18.9K | 0.05% | 262 |
|
|
2020
Q3 | $876K | Buy |
7,655
+228
| +3% | +$26.1K | 0.04% | 284 |
|
|
2020
Q2 | $834K | Buy |
7,427
+757
| +11% | +$85K | 0.05% | 286 |
|
|
2020
Q1 | $599K | Buy |
+6,670
| New | +$599K | 0.04% | 284 |
|